Insider Buys at Privia Health Group: Morris Matthew Shawn Acquires Shares
Morris Matthew Shawn purchased 88,110 shares of Privia Health Group at $2.00 each.
Key Points
- Morris Matthew Shawn bought 88,110 shares of Privia Health Group at $2.00 each, totaling $176,220.
- Shares of Privia Health Group traded near $25.55 on Wednesday, with a market cap of $3.24 billion.
- Analysts maintain a mix of 'hold' and 'buy' ratings, with a target mean price of $31.42.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 26, 2026, Morris Matthew Shawn made a notable move by purchasing 88,110 shares of Privia Health Group, Inc. (NasdaqGS: PRVA) at a price of $2.00 per share. This transaction, valued at $176,220, was not part of a pre-planned trading program.
Insider Buying and Selling at Privia Health Group, Inc.
Morris Matthew Shawn was not the only insider trading shares of Privia Health Group recently. On June 29, 2026, he sold 63,212 shares, while David Mountcastle, the EVP & Chief Financial Officer, bought 17,196 shares at $2.00 on June 26, 2026, also under unplanned circumstances.
Other Institutional Activity in Privia Health Group
Several institutional investors have also been active in Privia Health Group. BlackRock, Inc. increased its holdings by 93,747 shares, bringing its total to 19,057,910 shares valued at approximately $392.02 million. FMR LLC boosted its stake by 995,493 shares to hold 13,045,542 shares worth about $268.35 million, marking an 8.3% increase. Vanguard Portfolio Management LLC initiated a new position with 6,281,542 shares valued at $129.21 million. Meanwhile, Rubicon Founders LLC added 175,142 shares, increasing its holdings by 3% to a total of 5,948,664 shares valued at $122.36 million.
Privia Health Group, Inc. Stock Up 22.9%
Shares of Privia Health Group traded near $25.55 on Wednesday. The company has a market cap of $3.24 billion and a P/E ratio of 151.35, reflecting its growth expectations. The stock's 52-week range is between $18.77 and $26.51, with a 50-day moving average of $23.27 and a 200-day moving average of $23.34. Privia Health maintains a current ratio of 1.61 and a debt-to-equity ratio of 1.12, indicating solid financial health.
$PRVA stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
Analyst opinions on Privia Health Group are varied. On May 26, 2026, Barclays maintained a 'hold' rating with a $24.00 price target. Canaccord Genuity has a 'buy' rating with a target of $34.00 set on May 8, 2026. The consensus target price among analysts is $31.42, with 19 opinions contributing to this average.
About Privia Health Group
Privia Health Group, Inc. is a healthcare company based in Arlington, Virginia. It partners with physician practices, health plans, and health systems across the United States to improve healthcare delivery. The company offers technology solutions and management services that help reduce administrative burdens for healthcare providers. Privia Health also operates accountable care organizations to enhance patient care and reduce costs. Led by CEO Parth Mehrotra, the company employs over 1,200 people.
Bottom Line
Insider actions at Privia Health Group, like Morris Matthew Shawn's recent purchase, can offer insights into the company's internal sentiment. Investors often watch these moves closely, although they shouldn't be seen as definitive signals of future performance. Privia Health's strong financial metrics and active institutional interest highlight its position in the healthcare sector. As always, it's crucial to remember that insider transactions and institutional filings are historical and may not reflect the current state of holdings.
Get Privia Health Group, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PRVA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.